BCAB

Question 1

Who is the CEO of Bioatla Inc?

Accepted Answer

Dr. Jay Short is the Chairman of the Board of Bioatla Inc, joining the firm since 2007.

Question 2

What is the price performance of BCAB stock?

Accepted Answer

The current price of BCAB is $0.7909, it has increased 4.97% in the last trading day.

Question 3

What are the primary business themes or industries for Bioatla Inc?

Accepted Answer

Bioatla Inc belongs to Biotechnology industry and the sector is Health Care

Question 4

What is Bioatla Inc market cap?

Accepted Answer

Bioatla Inc's current market cap is $46.4M

Question 5

Is Bioatla Inc a buy, sell, or hold?

Accepted Answer

According to wall street analysts, 3 analysts have made analyst ratings for Bioatla Inc, including 3 strong buy, 3 buy, 3 hold, 0 sell, and 3 strong sell

Bioatla Inc (BCAB) Price

BCAB Stock Price Chart

Related News

BioAtla to Announce Q3 2025 Financial Results Amid Operational Restructuring

BioAtla Reports 21.5-Month Median Survival in Refractory Sarcoma Trial for Mecbotamab Vedotin

BioAtla Secures up to $22.5 Million in Flexible Financing Ahead of Strategic Partnership Decision

Follow-Up Questions

Who is the CEO of Bioatla Inc?

What is the price performance of BCAB stock?

What are the primary business themes or industries for Bioatla Inc?

What is Bioatla Inc market cap?

Is Bioatla Inc a buy, sell, or hold?

Related News

BioAtla to Announce Q3 2025 Financial Results Amid Operational Restructuring

BioAtla Reports 21.5-Month Median Survival in Refractory Sarcoma Trial for Mecbotamab Vedotin

BioAtla Secures up to $22.5 Million in Flexible Financing Ahead of Strategic Partnership Decision

Follow-Up Questions

Who is the CEO of Bioatla Inc?

What is the price performance of BCAB stock?

What are the primary business themes or industries for Bioatla Inc?

What is Bioatla Inc market cap?

Is Bioatla Inc a buy, sell, or hold?